BCRX
BioCryst Pharmaceuticals Inc. Healthcare - Biotechnology Investor Relations →
BioCryst Pharmaceuticals Inc. (BCRX) closed at $6.38 as of 2026-02-02, trading 23.1% below its 200-week moving average of $8.30. This places BCRX in the extreme value zone. The stock is currently moving closer to the line, down from -20.9% last week. The 14-week RSI sits at 34, indicating neutral momentum.
Over the past 1618 weeks of data, BCRX has crossed below its 200-week moving average 19 times. On average, these episodes lasted 49 weeks. The average one-year return after crossing below was -12.4%, suggesting these dips have not historically been reliable buying opportunities for this stock.
With a market cap of $1582 million, BCRX is a small-cap stock. The company generates a free cash flow yield of 4.0%. The stock trades at -3.5x book value.
Share count has increased 13.1% over three years, indicating dilution.
Over the past 31.1 years, a hypothetical investment of $100 in BCRX would have grown to $111, compared to $2426 for the S&P 500. BCRX has returned 0.3% annualized vs 10.8% for the index, underperforming the broader market over this period.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Growth of $100: BCRX vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After BCRX Crosses Below the Line?
Across 19 historical episodes, buying BCRX when it crossed below its 200-week moving average produced an average return of -12.9% after 12 months (median -34.0%), compared to +10.1% for the S&P 500 over the same periods. 17% of those episodes were profitable after one year. After 24 months, the average return was +32.4% vs +18.2% for the index.
Each line shows $100 invested at the moment BCRX crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
BCRX has crossed below its 200-week MA 19 times with an average 1-year return of +-12.4% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Sep 1997 | Jul 1999 | 96 | 42.7% | -27.3% | -33.7% |
| Oct 2000 | Nov 2003 | 160 | 93.4% | -49.4% | -5.0% |
| Nov 2003 | Mar 2004 | 15 | 21.4% | -24.1% | -22.4% |
| Jul 2004 | Jul 2004 | 1 | 1.4% | +38.3% | +32.9% |
| Mar 2005 | Jun 2005 | 12 | 11.6% | +311.4% | +45.3% |
| Mar 2007 | Apr 2007 | 2 | 7.6% | -51.5% | -23.8% |
| Apr 2007 | Aug 2007 | 15 | 23.4% | -56.8% | -26.9% |
| Sep 2007 | Jul 2009 | 96 | 88.9% | -61.5% | -20.1% |
| Dec 2009 | Jan 2010 | 4 | 20.6% | -26.3% | -4.8% |
| Jan 2010 | Mar 2010 | 6 | 7.0% | -37.7% | -6.5% |
| Mar 2010 | Mar 2010 | 2 | 1.4% | -48.9% | -5.2% |
| Jun 2010 | Feb 2012 | 90 | 48.8% | -44.4% | N/A |
| Apr 2012 | Jul 2013 | 68 | 75.2% | -61.0% | +46.3% |
| Jan 2016 | Mar 2017 | 60 | 77.4% | -16.2% | -14.5% |
| Apr 2017 | Aug 2018 | 70 | 50.2% | -36.6% | -12.1% |
| Oct 2018 | Oct 2018 | 1 | 1.7% | -60.1% | -5.8% |
| May 2019 | Nov 2020 | 80 | 67.5% | +64.2% | +92.2% |
| Feb 2023 | May 2025 | 114 | 57.9% | -36.1% | -27.4% |
| Jun 2025 | Ongoing | 33+ | 25.9% | Ongoing | -31.8% |
| Average | 49 | — | +-12.4% | — |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02